ABSTRACT YOUMANS, ANNE S. (Northwestern University Medical School, Chicago, Ill.), AND GuY P. YOUMANS. Effect of trypsin and ribonuclease on the immunogenic activity of ribosomes and ribonucleic acid isolated from Myobacterium tuberculosis.
H37Ra, of Mycobacterium tuberculosis was treated with trypsin alone, ethylenediaminetetraacetic acid (EDTA) alone, EDTA and pancreatic ribonuclease, or with trypsin and ribonuclease. After each of these treatments, the ribosomal fractions were injected intraperitoneally into male CF-1 mice to test their capacity to produce an immune response to infection with virulent tubercle bacilli, strain H37Rv. Removal of protein with trypsin left the immunogenicity unchanged; EDTA alone reduced immunogenicity in the smaller vaccinating doses; EDTA plus ribonuclease reduced the immunogenicity by approximately 50% in the highest (1.0 mg) vaccinating dose; ribonuclease alone, after treatment with trypsin, reduced immunogenicity also approximately 50%. A crude mycobacterial ribonucleic acid (RNA) was prepared by extraction of the ribosomal fraction with alcohol. This RNA preparation was as effective in producing an immune response as the ribosomal fraction from which it was prepared, unless the RNA was partially or completely degraded during the preparation. The effect of ribonuclease on the immunogenicity of the RNA was similar to that obtained with the ribosomal fractions, except that ribonuclease completely destroyed the immunogenicity of a partially degraded RNA. RNA appears to be an essential part of an immunizing substance in attenuated tubercle bacilli, which produces a high degree of immunity in mice; 50 Ag (dry weight) will protect approximately 80% of the mice, and as little as 0.5 ,ug will protect approximately 30% of the mice. Mycobacterial RNA not incorporated in Freund's incomplete adjuvant was nonimmunogenic. Yeast RNA incorporated in Freund's incomplete adjuvant was not immunogenic.
In the previous paper (37), methods were described in which sodium dodecyl sulfate (SDS) was used to prepare mycobacterial ribosomal fractions. These fractions were immunogenic in mice when administered in much smaller vaccinating doses than had been found to be active previously (33) (34) (35) (36) . Having obtained more active and more stable ribosomal preparations, experiments were devised to determine whether the entire ribosomal particle was needed to produce the immune response or whether one of its two compenents, ribonucleic acid (RNA) or protein, was the immunizing moiety. The results suggest that RNA is the immunogenic substance.
MATERIALS AND METHODS
The methods and materials, including the preparation of the SDS ribosomal fraction, were the same as those given in the previous paper. Certain other experimental details will be given with the results. All vaccine preparations were administered to mice in Freund's incomplete adjuvant unless otherwise noted.
RESULTS
To help define the role of protein in the immunogenic process, crystalline trypsin was added to a portion of the ribosomal preparation (0.05 mg/mg of ribosomal fraction, pH 7.0) and incubated at 37 C for 30 min. This amount of trypsin was added to the phosphate-magnesium buffer which served as the blank. Protein was determined by the method of Lowry et al. (14) , and the average amount for the preparations is given in Table 1 In another experiment, the ribosomal fraction was treated with trypsin at 37 C for 30 min to remove ribosomal protein, and then ribonuclease was added and the incubation was continued for 30 min. Ribonuclease decreased the number of survivors from 75 to 35 % in the mice vaccinated with the 1-mg dose, a reduction of 51 %. Of the mice given the 0.1-mg dose, 61 % survived in comparison with 38 % which survived when given the same amount of ribonuclease-treated material, a reduction of 38%.
Thus, a fairly large amount of ribonuclease was able to destroy only about 50% of the immunogenic activity. As a result, in the next five experiments a crude preparation of mycobacterial RNA was used to determine the activity of ribonuclease on mycobacterial RNA, and also to determine the immunogenic activity of this RNA.
The method used to extract the RNA followed, in part, the method devised by Crestfield, Smith, and Allen (4) for the isolation of RNA from yeast. The ribosomal fraction (20 mg/ml) was added to 2 volumes of cold 95% ethyl alcohol. To achieve precipitation of the RNA, it was necessary to add 2 M NaCl. The amount added varied from 10 to 12 drops for a small volume, such as 30 ml, to several ml for a larger volume, but was sufficient to produce a gel-like flocculation upon standing at 0 C for approximately 30 min. This material then was centrifuged in the cold at 2,000 rev/min for 15 to 20 min. The supernatant fluid was discarded from the tightly packed gel-type white precipitate. The precipitate was suspended in distilled water (pH 7.0), and a Teflon grinder was used, when necessary, to gently homogenize the material. It was found that the precipitate could not be weighed accurately, as it apparently absorbed moisture during the alcohol extraction and was heavier than the original. The precipitate, therefore, was diluted to half the original volume, since experience showed that approximately half of the RNA was lost. The amount of RNA was measured by ultraviolet absorption. It was then diluted with distilled water so that the amount of RNA present was the same as the RNA content of the ribosomal fraction from which it was extracted.
The UV spectrum of this mycobacterial RNA was similar to spectra found with RNA extracted from other sources. The peak absorption was at 258 m,u. The 260:280 ratio was 1.8. These preparations of RNA were unstable at 37 C for 30 min, since after this time only acid-soluble fragments remained.
Dry weights were determined on samples of the crude RNA in four of the five experiments (Table 4 ). The amount of RNA averaged 2.1 mg/ml and protein averaged 1.2 mg/ml; there- The results of one experiment were not included in this table, because the mycobacterial RNA did not immunize as well as the ribosomal fraction from which it was extracted, although the amount of RNA in each preparation was the same (45 ,ug/mg). These data are shown in Table 6 . It was found that there was a correlation between the low immunizing activity and the amount of RNA degradation as measured by the absorption increment. The procedure for measuring the absorption increment followed that given by Hotchkiss (11) . A portion of the mycobacterial RNA (1 mg/ml) was divided into two equal volumes (4.0 ml), and to one was added ribonuclease (0.1 mg/mg RNA). The same amount of ribonuclease was added to the same volume of distilled water to serve as a blank. The three mixtures stood at room temperature for 15 min, and the optical densities were then measured at 260 m,u. The difference obtained between the readings was divided by the original RNA reading to give the per cent increase in absorption increment. The increase for this preparation of RNA was only 10.8%; this indicated considerable degradation of the nucleic acid during its extraction. This finding was in contrast to the other three preparations of RNA given in Table  3 , in which the average per cent increase in the absorption increment was 39%. This latter figure denotes RNA of good quality with little or no degradation (11) . These results suggest, there- In the first experiment in which RNA was prepared, it was found that this preparation of mycobacterial RNA, in contrast to the ribosomal fractions, was not stable at 37 C for 30 min. The RNA, at this temperature, broke down completely into acid-soluble fragments. Mice vaccinated with RNA treated at 37 C (with or without the addition of ribonuclease) showed no immune response, although the RNA kept at 0 C was as immunogenic as the ribosomal fraction from which it was extracted. These results again indicated that the RNA must be of high quality with little or no degradation in order to achieve a maximal immune response.
In two of the experiments, ribonuclease (0.1 mg/mg of RNA) was added to a portion of the RNA and allowed to stand at room temperature for 30 min, since the RNA appeared to be quite stable under these conditions. A room temperature control RNA sample and a 0 C control RNA sample were included also. After standing, the room temperature preparations were immersed in ice, and a portion was removed to test for the presence of acid-insoluble nucleic acid in order to determine the activity of ribonuclease under these conditions. It was found in the two experiments that ribonuclease decreased the acid-insoluble material by 50%, indicating that pancreatic ribonuclease does not hydrolyze completely mycobacterial RNA.
The animal experiments in which the mice were vaccinated with these preparations confirmed the chemical data in several ways. Since different results were obtained with these two ribonuclease-treated preparations, the data from each experiment are given separately. The data in Table 6 show that ribonuclease completely removed the immunogenic activity of the partially degraded RNA. As shown in Table 7 The studies done to determine the effect of ribonuclease upon the immunogenic activity of the ribosomes and upon RNA extracted from the ribosomes revealed that only approximately 50% of the immunogenic activity was lost. This could be accounted for by the presence of a ribonuclease-resistant RNA core which still has the capacity to immunize. Pancreatic ribonuclease will hydrolyze pyrimidine-phosphate ester bonds but not purine-phosphate ester bonds. The ratio of purine to pyrimidine in RNA extracted from M. bovis (strain BCG) is 1.25 (24) or 1.08 (28) , and possibly the same in the human, H37Ra strain, so there might be a purine polynucleotide core which would remain unhydrolyzed. In addition, Roth and Milstein (19) found that small quantities of detergent will inhibit ribonuclease activity, and the ribosomal preparations used in this study all had small amounts of SDS present. Attardi and Smith (2) and Pirie (17) suggested that the presence of protein, or a protein coat, may prevent ribonuclease from hydrolyzing poliomyelitis virus RNA. Other investigators (16, 27 ) also have found ribosomal RNA to be somewhat refractory to the enzymatic activity of pancreatic ribonuclease. It may be that, with purer preparations of mycobacterial RNA, ribonuclease may be more active. It should be added that in a few experiments in which the largest amount of ribonuclease (1.0 mg) employed has been incorporated alone into Freund's incomplete adjuvant and injected intraperitoneally into mice, a low-grade, nonspecific increase in resistance (20 to 25% survival) to tuberculous infection has been noted. This would be insufficient to account for all of the residual immunizing activity following ribonuclease treatment of the ribosomal fractions, and, in the experiments using RNA, the amounts of ribonuclease employed were too small to produce any such response alone.
However, the 50% reduction in immunogenic activity by ribonuclease is of greater significance than may be immediately apparent. It should be realized that a 10-fold dilution of the ribosomal fraction will decrease the immunogenic activity by only about 30%, and a 100-fold dilution of the ribosomal fraction will decrease the immunogenic activity by only about 60%. Therefore, the 50% reduction produced by ribonuclease may represent the hydrolysis of the major portion of the mycobacterial RNA.
Of particular significance were the findings that if the RNA became degraded during preparation, or by exposure to higher temperatures, the immunogenic activity also was decreased or destroyed. For example, all the activity was lost by treatment at 37 C, and the RNA was found to be degraded completely into acid-soluble fragments. This demonstrated not only that the acid-soluble fragments are not immunogenic, but that mycobacterial RNA can be degraded by means other than the action of endogenous ribonuclease; this has been noted with RNA from other sources (9, 21, 29) .
EDTA apparently had no effect on the ribonuclease activity, even though it may have removed the magnesium ions. These ions have been reported to be inhibitory to the enzymatic action of ribonuclease (13, 17, 20) . However, EDTA alone, when added to the ribosomal fraction, reduced the immunogenic activity. No acid-soluble fragments were produced, though, after 30 min of exposure to this agent at room temperature or at 37 C. Palade and Siekevitz (16) found that EDTA damaged ribosomal particles from liver microsomes, resulting in a loss of 60 to 70% of the RNA. Chao (3) reported that EDTA dissociated yeast ribosomes, and Madison and Dickman (15) found aggregation of beef pancreas ribosomes in the presence of EDTA. The effect of EDTA on the ribosomes extracted from Escherichia coli and Pseudomonas fluorescens was studied by Wade and Robinson (31) , and they found a marked difference between the two strains, dependent on the presence of endogenous ribonuclease.
The role of Freund's incomplete adjuvant is not clear, but it would be reasonable to assume that it's major action is protective, preventing the RNA from being rapidly destroyed by host ribonuclease immediately after injection. Roth and Milstein (19) examined the ribonuclease content of rat tissues and found it present in all tissues examined, including serum. Since ribonuclease is present throughout the host, RNA injected alone would probably be degraded rapidly and would not produce an immune response, thus accounting for the lack of immunogenicity of mycobacterial RNA when not incorporated in adjuvant. Schwartz and Rieke (22) have shown that radioactive macromolecular RNA was incorporated into mouse macrophages after intraperitoneal injection. However, there was evidence that the RNA was partially degraded either before or shortly after it was taken up by the cells. Sved (26) has shown that RNA is rapidly hydrolyzed in the mouse when injected intravenously. In addition, Herriott, Connolly, and Gupta (10) and Alexander et al.
(1) have shown that normal sera contain ribonuclease which destroys biologically active poliovirus RNA. Therefore, the heavy adjuvant would provide a protective coating for the RNA until it is taken up by macrophages, and perhaps for some time after ingestion.
The cell walls of whole cells, or the natural membranous adjuvant present in the particulate fraction, no doubt would protect the RNA in a similar fashion.
The mechanism whereby mycobacterial RNA might induce an immune response against tuberculosis in the mouse also is not known. Certainly, however, the RNA must provide a stimulus which in some manner eventually results in the proliferation of a population of macrophages which have a greater capacity to inhibit the multiplication of virulent tubercle bacilli. One can only speculate on how this might occur. First, an antibody to RNA might be formed which in turn would have the capacity to inhibit the multiplication of virulent tubercle bacilli. The absence of a circulating protective antibody against M. tuberculosis in immunized animals is well documented (18, 25) , although Jenkin and Rowley (12) have suggested that a cell-bound antibody might be involved. Even if an antibody should be produced against RNA, it is difficult to visualize how this could combine with and affect the RNA inside of a living tubercle bacillus.
Second, mycobacterial RNA might, in some unknown fashion, stimulate the production of an adaptive enzyme or other substance which would have an inhibitory effect on mycobacterial growth. In regard to the latter possibility, Youmans and Youmans (32, 38) reported that a substance, which we called mycosuppressin, had been detected in the lungs of immunized guinea pigs and rabbits. Mycosuppressin inhibited the respiration and growth of virulent tubercle bacilli both in vitro and in vivo, and did not affect unrelated microorganisms. The nature of mycosuppressin is unknown, but it may be an adaptive enzyme, or it may be a substance normally present in the tissues, which increases greatly in amount after immunization. Conceivably, mycobacterial RNA might stimulate an overproduction of ribonuclease which would then function to inhibit growth. In this connection, Enright, Frye, and Atwall (5) showed an increase in ribonuclease in mice refractory to rabies, and suggested that the refractory state might be accounted for by the inactivation of the viral RNA by ribonuclease.
Third, even though the mycobacterial immunizing material is composed largely of RNA, and the immunizing activity is decreased by ribonuclease, there is a possibility that the RNA is only indirectly involved. Fishman (6) and Fishman and Adler (7) have shown that RNA from macrophages exposed to T2 bacteriophage would transfer to rat lymph node cells the capacity to form antibodies against bacteriophage T2 antigens. The capacity of macrophage RNA to confer antibody-producing properties on lymph node cells was abolished by treatment with ribonuclease. More recently, Friedman, Stavitsky, and Solomon (8) showed that such macrophage RNA preparations always contain small amounts of T2 antigens. They also found that the transfer of capacity to produce antibody was greatly reduced after treatment of the macrophage RNA preparations with ribonuclease. They suggested that the macrophages rapidly degrade the T2 antigen and then bind the antigen fragments to certain low molecular weight RNA molecules of the cell, thereby holding the antigens in native, immunogenic configuration. In addition, the RNA may function as an intracellular adjuvant. The RNA in our preparations might function similarly, binding an as yet unidentified immunizing component of the mycobacterial cell and maintaining the immunizing configuration. Or, if the immunizing component is of low molecular weight, it may be immunogenic (antigenic?) only when complexed with a large molecule such as RNA. It has been shown that nucleosides can function in this manner (23) . In either case, degradation of the RNA by ribonuclease prior to being introduced into cells would greatly reduce the immunizing activity, though not necessarily completely.
Finally, the possibility should be considered that mycobacterial RNA might attach to ribosomes in macrophages, or other cells, and replicate or direct the production of mycobacterial protein in a manner analogous to RNA viruses. This, in turn, might produce a refractory state within these cells, again in a manner analogous to the refractory state produced by latent virus infection. This theory may seem far-fetched, but there are too many unknown aspects of the phenomenon of latency of mycobacteria in healthy hosts to permit it to be arbitrarily dismissed.
